Identification of Compound Isolated From Cock's Comb and Its Effect on Arsenical Palmar Keratosis
NCT03635853 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 40
Last updated 2018-08-17
Summary
Arsenicosis is a massive public health hazard in Bangladesh. Prolonged consumption of water containing high concentration arsenic leads to arsenicosis which is characterized by dermatological features i.e. diffuse melanosis , spotted melanosis and keratosis. Cock's comb is rich in hyaluronic acid, chondroitin sulfate A, B, C and heparin. Hyaluronic acid is a hydrophilic molecules and is a constituent of wound extracellular matrix and facilitate wound healing.This work is aimed to identify the component that is effective in palmar arsenical keratosis.
Conditions
- Improvement of Keratotic Nodular Size
Interventions
- DRUG
-
drug containing extract from cock's comb
a container containing 25 mg of ointment having extract from cock's comb as active ingredient two times daily for 3 months
Sponsors & Collaborators
-
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
lead OTHER
Principal Investigators
-
Hazera Sharmin, MBBS · Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 60 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-09-16
- Primary Completion
- 2018-12-31
- Completion
- 2019-02-28
Countries
- Bangladesh
Study Locations
More Related Trials
-
Efficacy of Botulinum Toxin In Scleroderma-Associated Raynaud's Syndrome
NCT02165111 ·Status: COMPLETED ·Phase: PHASE3
-
Expression of miRNa-138 and Cyclin D1 in Oral Mucosa of Patients With Oral Lichen Planus
NCT02834520 ·Status: COMPLETED
-
Study of TD101, a Small Interfering RNA (siRNA) Designed for Treatment of Pachyonychia Congenita
NCT00716014 ·Status: COMPLETED ·Phase: PHASE1
-
Fire Needle Therapy on Plaque Psoriasis With Blood Stasis Syndrome
NCT03953885 ·Status: UNKNOWN ·Phase: NA
-
Topical Sirolimus in Patients With Basal Cell Nevus Syndrome and in Healthy Participants
NCT00433485 ·Status: COMPLETED ·Phase: PHASE1
-
Trichoscopy in Diagnosis of Immunobollous Diseases
NCT03478072 ·Status: UNKNOWN
-
Short-term Function and Pain After Treatment for Dupuytren's Disease
NCT02301078 ·Status: UNKNOWN
-
Mechanistic Study of Indigo Naturalis in Treating Psoriasis
NCT02088281 ·Status: COMPLETED ·Phase: PHASE2
-
Safety, Tolerability, and Pharmacokinetics of CAT-192 (Human Anti-TGF-Beta1 Monoclonal Antibody) in Patients With Early Stage Diffuse Systemic Sclerosis
NCT00043706 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Effects of Arsenic on Keratinocytes in a Skin Equivalent Model
NCT00166946 ·Status: UNKNOWN ·Phase: NA
-
Effectiveness of the Henna Application in Patients with Hand-Foot Syndrome: Nested Case-Control Study
NCT06832501 ·Status: COMPLETED
-
Evaluation of Serum and Tissue Cathepsin L in Non-segmental Vitiligo Patients
NCT06261073 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
A Study of FCX-007 for Recessive Dystrophic Epidermolysis Bullosa
NCT04213261 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Topical Cosmetic Products for Hand and Foot Syndrome
NCT06586073 ·Status: COMPLETED
-
Histological Characterization and Differentiation of Rash From Other Epidermal Growth Factor Receptor (EGFR) Inhibitors
NCT00709878 ·Status: COMPLETED
-
Cytodiagnosis of Basal Cell Carcinoma and Actinic Keratosis Using Papanicolaou and May-grunwald-giemsa Stained Tissue Smear
NCT00218868 ·Status: COMPLETED
-
A Phase 3 Study of KHK4827 in Patients With Systemic Sclerosis
NCT03957681 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of FCX-013 Plus Veledimex for the Treatment of Moderate to Severe Localized Scleroderma (Morphea)
NCT03740724 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Oral Type I Collagen for Relieving Scleroderma
NCT00005675 ·Status: COMPLETED ·Phase: PHASE2
-
Genesis of Scleroderma: Role of Environmental Factors in 100 Patients With Scleroderma and 300 Controls
NCT00213525 ·Status: COMPLETED
-
Topical Sirolimus for the Treatment of Pachyonychia Congenita (PC)
NCT02152007 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy and Safety of Oral Bosentan on Healing/Prevention of Digital (Finger) Ulcers in Patients With Scleroderma
NCT00077584 ·Status: COMPLETED ·Phase: PHASE3
-
Lenalidomide in the Treatment of Refractory Cutaneous Dermatomyositis
NCT05488327 ·Status: UNKNOWN ·Phase: NA
-
Exploring Patient Reported Outcomes in Inherited Ichthyosis
NCT06123091 ·Status: RECRUITING
-
Physiopathological Study and Pharmacological Modulation of Cutaneous Atrophy's Markers Induced by Glucocorticoids
NCT00709579 ·Status: UNKNOWN ·Phase: PHASE3